Related Experiment Videos
Ziprasidone overdose: cardiac safety
F J Insa Gómez1, J R Gutiérrez Casares
1Complejo Hospitalario Universitario, Badajoz, Spain. fjinsa@cavabianca.org
Abstract:
Ziprasidone is a neuroleptic drug recently sold in Spain. According to its profile of receptors it is considered an atypical or second generation antipsychotic agent. Its use has been associated to increase of the QT interval, which might trigger potentially lethal ventricular arrhythmia. We present a case of overdose with moderate doses of the drug, in which there were no important changes in the QT interval. A review of the cases of overdose published up to now was also done.
Related Concept Videos
Drug Toxicity: Risk factors
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies